IPSC icon

Century Therapeutics

1.70 USD
+0.03
1.8%
At close Updated Feb 6, 4:00 PM EST
Pre-market
After hours
1.75
+0.05
2.94%
1 day
1.8%
5 days
-10.05%
1 month
88.89%
3 months
214.81%
6 months
213.42%
Year to date
70.87%
1 year
122.83%
5 years
-92.55%
10 years
-92.55%
 

About: Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.

Employees: 165

0
Funds holding %
of 7,552 funds
0
Analysts bullish %
of 2 analysts
Positive news %
of articles
Price charts implemented using Lightweight Charts™